The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Other Relationship - FKD Therapies

Intravesical rad-IFNα/Syn3 for patients with high-grade, bacillus Calmette-Guérin (BCG) refractory or relapsed non-muscle invasive bladder cancer: A phase II randomized study.
 
Stephen A. Boorjian
Consulting or Advisory Role - Astellas Medivation
 
Neal D. Shore
Consulting or Advisory Role - Bayer; Dendreon; Ferring; Janssen Scientific Affairs; Medivation/Astellas; Sanofi; Takeda; Tolmar
 
Daniel Canter
No Relationships to Disclose
 
Kenneth Ogan
No Relationships to Disclose
 
Lawrence Ivan Karsh
Stock and Other Ownership Interests - Swan Valley Medical
Honoraria - Astellas Pharma; Bayer; Dendreon; Janssen; Medivation/Astellas
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Janssen; Medivation/Astellas
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Dendreon; Janssen; Medivation
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Dendreon (Inst); Janssen (Inst); Medivation/Astellas (Inst); Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; dendreon; Janssen; Medivation/Astellas; Spectrum Pharmaceuticals
 
Tracy Downs
No Relationships to Disclose
 
Leonard G. Gomella
Research Funding - FKD Therapies
 
Ashish M. Kamat
Honoraria - Pacific Edge
Consulting or Advisory Role - Abbott Molecular; Heat Biologics; Merck; Photocure; Sanofi; Spectrum Pharmaceuticals; Telesta Therapeutics; Theralase
Research Funding - FKD Therapies; Heat Biologics; Merck; Photocure
 
Yair Lotan
Consulting or Advisory Role - Augmenix; BioCancell; MDxhealth; Physical Optics Corporation; SonaCare Medical
Research Funding - Abbott Molecular; Cepheid; Danone; Metabolon; pacific edge
 
Robert S. Svatek
No Relationships to Disclose
 
Trinity J. Bivalacqua
No Relationships to Disclose
 
Robert Grubb
No Relationships to Disclose
 
Tracey Krupski
No Relationships to Disclose
 
Seth P. Lerner
Consulting or Advisory Role - BioCancell; Ferring; UroGen pharma; Vaxiion
Other Relationship - Endo Pharmaceuticals; Roche/Genentech; Viventia Biotech
 
Michael Woods
No Relationships to Disclose
 
Brant Allen Inman
Consulting or Advisory Role - AstraZeneca; Combat Medical; Taris
Other Relationship - Abbott; Dendreon; GlaxoSmithKline; Roche/Genentech
 
Matthew I. Milowsky
Research Funding - Acerta Pharma (Inst); Astellas Pharma (Inst); BIND Therapeutics (Inst); Cerulean Pharma (Inst); Dendreon (Inst); Exelixis (Inst); Johnson & Johnson (Inst); Merck (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); Seagen (Inst); Tokai Pharmaceuticals (Inst)
 
Nigel Parker
Leadership - FKD Therapies
Travel, Accommodations, Expenses - FKD Therapies
 
David Sawutz
Leadership - FKD Therapies
Consulting or Advisory Role - FKD Therapies
Travel, Accommodations, Expenses - FKD Therapies
 
Colin P.N. Dinney
No Relationships to Disclose